Interview with Victor Bulto, President, US, Novartis

Описание: In this important podcast episode, we interview Victor Bulto, President, US for Novartis, to discuss the company's efforts to develop groundbreaking treatments while ensuring accessibility and affordability for patients. We delve into how the pharmaceutical industry navigates numerous post-FDA approval barriers to launch new drugs and the importance of market access, patient support services, and a commitment by manufacturers to provide patient assistance and other support for patients.

Victor Bulto, President, Novartis
https://www.novartis.com/about/execut...

Novartis
https://www.novartis.com/

FDA
https://www.fda.gov/

Institute for Clinical and Economic Review (ICER)
https://icer.org/

American Heart Association (AHA)
https://www.heart.org/

Inflation Reduction Act (IRA)
https://home.treasury.gov/policy-issu...

Pharmacy Benefit Manager (PBM)
https://en.wikipedia.org/wiki/Pharmac...

Medicare
https://www.medicare.gov/

Medical terminology referenced in this episode:

Cell therapy: CART-T
https://www.cancer.org/cancer/managin...

Radioligand therapy
https://www.ncbi.nlm.nih.gov/pmc/arti...

RNA
https://en.wikipedia.org/wiki/RNA

Entresto
https://www.entresto.com/

Molecular glues
https://en.wikipedia.org/wiki/Molecul...

Targeted protein degradation
https://www.protein-degradation.org/

Antisense oligonucleotides
https://en.wikipedia.org/wiki/Antisen...

Small interfering RNAs: siRNAs
https://en.wikipedia.org/wiki/Small_i...

LDL cholesterol
https://www.cdc.gov/cholesterol/ldl_h...

COVID
https://www.cdc.gov/coronavirus/2019-...

Hematological malignancies
https://www.accc-cancer.org/home/lear...

Refractory autoimmune diseases
https://www.sciencedirect.com/science...

Questions or comments?
Email us at [email protected].
Find us on social media! Follow us on
X
  / rx4betteraccess  

LinkedIn
  / rxbetteraccess  

YouTube
   / @prescriptionforbetteraccess  

and

Threads.
https://www.threads.net/@prescription...